Platelet-Rich Plasma from Two Different Systems in Knee Osteoarthritis
Official title: Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems
Run by University of California, San Francisco · NCT07491367 · Data updated 2026-11-12
This study compares PRP made by two FDA-approved machines to see if the platelets differ and whether injections help knee symptoms.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Drugs / interventions | chemotherapy, prednisone |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07491367 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Kellgren-Lawrence grade 1–3 knee osteoarthritis, at least 3 months of knee symptoms, and ability to complete physical therapy.
✕Probably not a fit
Individuals with advanced knee arthritis, recent knee injections, or conditions excluding PRP therapy may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase 4 interventional study evaluates differences in the quality of platelet-rich plasma produced by two commercial systems in adults with knee osteoarthritis. Participants will receive PRP prepared with either the APEX Biologix XCELL PRP System or the Emcyte PurePRP system, and outcomes on knee symptoms will be tracked after injection. The study also examines whether the two preparation methods yield PRP with different platelet counts or functional properties. Eligibility includes adults with KL grade 1–3 OA, persistent knee symptoms, and ability to participate in physical therapy. Exclusion criteria cover recent injections, prior knee surgeries, bleeding disorders, immunocompromise, active cancer, and other knee-affecting conditions.
Why it matters
Potential benefit: Participants may experience symptom relief from PRP injections, and the study may clarify whether one system produces higher-quality PRP leading to better outcomes.
How similar studies have gone: Previous work suggests PRP quality and preparation method can influence outcomes, but direct head-to-head comparisons like this are less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Kellgren-Lawrence (KL) Grade 1-3 knee osteoarthritis * Symptoms of knee osteoarthritis for at least 3 months before presentation in one knee * Will be able to attend and perform physical therapy Exclusion Criteria: * Received injection therapy for knee osteoarthritis in the past 6 months * Have severe arthritis diagnosed in ≥1 major joint by radiology criteria * History of septic arthritis * Underwent knee surgery for osteoarthritis or osteochondral defects within 1 year before randomization (e.g., autograft or allograft surgery) * Have had high tibial osteotomy, partial knee replacement, patellar resurfacing, total knee replacement, or have existing surgical hardware in the knee * Received a platelet-rich plasma injection elsewhere in the body within the past 3 months * Have a platelet disorder or bleeding disorder * Have a rheumatologic disease, autoimmune disorder, immunocompromised status, or active history of cancer * Are taking chemotherapy, require regular prednisone, or require regular anti-inflammatory use * Are pregnant, breastfeeding, or unwilling to practice birth control during the study * If both knees have osteoarthritis and the other knee has KL score equal to or greater than 2. * Have uncontrolled illness, physical disability, or other contraindication to aerobic exercise training
Where it's running
-
University of California San Francisco
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Anthony Luke, MD — University of California, San Francisco
- Study coordinator: Joel Kopcow
- Email: joel.kopcow@ucsf.edu
- Phone: 970-590-0314
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NPT Feasibility in Knee Osteoarthritis
This study tests whether NRPT can be safely given to adults with knee osteoarthritis and whether it shows early signals of benefit.
-
Aquatic exercise for knee osteoarthritis and central sensitization
A water-based exercise program is being tested to see if it helps people aged 40–65 with knee osteoarthritis who also have central sensitization.
-
Gender-based test of a graded weight-bearing physiotherapy for knee osteoarthritis
We’re testing a 6-week, sensory-modulated graded weight-bearing physiotherapy to see if outcomes differ between men and women with knee osteoarthritis.
-
Does implant type affect knee alignment when using KUNWU robotic surgery
This trial tests whether two knee implants (Attune vs Persona) used with the KUNWU robotic system result in more accurate knee alignment after total knee replacement.
-
Outpatient physiotherapy vs. mHealth exercise and self-management for knee osteoarthritis
This study tests whether a mobile app–guided, self-managed knee OA exercise program is as good as traditional hospital-based therapy for improving walking speed in adults with knee OA.
-
Digital Rehab Program for knee OA using multisensory gear and digital twin tech
A digital rehabilitation program with a smart knee brace and real-time feedback is tested to help adults with knee OA improve movement and function at home.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.